Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E.

CASE:RMDA Stock Report

Market Cap: ج.م5.5b

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda)E Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of RMDA?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders43,569,4032.9%
Institutions172,576,81011.5%
Private Companies609,739,32440.6%
General Public677,579,39545.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 11 shareholders own 54.93% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
19.3%
Equinox Pharma Holding Ltd.
289,782,798ج.م1.1b3.09%no data
11.2%
The Saudi Seventh Investment Company
167,704,795ج.م613.8m0%no data
10.1%
Ekuity B.V.
152,251,731ج.م557.2m0%no data
6.66%
Blominvest Bank, Asset Management Arm
100,056,822ج.م366.2m-5.2%no data
3.3%
Russell Investment Management, LLC
49,682,000ج.م181.8m0%no data
2.23%
Amr Morsy
33,502,289ج.م122.6m0%no data
1.52%
Sanlam Investment Management (Pty) Ltd.
22,837,988ج.م83.6m0%0.02%
0.46%
Ahmed Mohammed Issameddin Mohammed Fahmi
6,935,500ج.م25.4m-25.1%no data
0.21%
Mahmoud Mustafa Salaheddine Fayek
3,115,767ج.م11.4m-13.8%no data
0.00053%
Ayman Mamdouh Mohamed Abbas
7,924ج.م29.2k0%no data
0.00053%
Shamel Aboul Fadl
7,923ج.م29.2k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/04 22:30
End of Day Share Price 2025/02/04 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. is covered by 12 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Eman MareeArab African International Securities
Ahmed RashadBeltone Financial
Aly AdelBeltone Financial